299 KNEE INJURY AND OSTEOARTHRITIS OUTCOME SCORE (KOOS) AND CARTILAGE BIOMARKERS IN MIDDLE-AGED WOMEN WITH EARLY OSTEOARTHRITIS (OA)  by TAMM, A.E. et al.
S132 Osteoarthritis and Cartilage Vol. 16 Supplement 4
completed SF-12 at preinjection and 6 months and an expectations
questionnaire prior to surgery. 20 patient expectation domains were
measured and analyzed individually, as “very important” to “of little to
no importance”.
17 patients dropped out due to non-medical reasons. Of 46 remaining, 27
were female, 18 male. Average age was 65 (range 42−81). 30 patients
(65%) reported previous knee surgery.
Results: All patients reported pain as reason for seeking medical treat-
ment. Pain relief was very important to only 66% of patients and some-
what important to 12%. If patients expected pain relief, 43% expected
most pain to be relieved. 36% expected all pain to be relieved. 17 (37%)
reported stiffness as primary reason for seeking medical treatment. Only
54% of patients expected knee stiffness/swelling to stop. Improving ability
to walk was considered very important in 89% and they expected to walk
more than 1 mile. 80% of patients considered return to recreational sports
an important expectation and somewhat important in 13%. The most
important expectation in this group was to have conﬁdence in their knee,
avoid future knee degeneration and improve ability to maintain general
health. All patients rated these important. Getting knee back to where it
was before problem started was only important in 66% of patients.
No patient discontinued injection series due to negative response to
injection. 3 (7%) required surgery prior to 6 month time-point. All 3 had
previous knee surgery. Average age of failures was 68 (range 66−70).
In the 43 patients, results showed positive response in initial weeks
following completion of injection series (Figure). Patients at 6 months
showed signiﬁcant improvement in pain, WOMAC score, Lysholm and
SF-12 physical component.
Pre-injection 6 months p-value
Lysholm 40 62 0.001
WOMAC Pain 7 5 0.004
WOMAC Total 28 23 0.047
SF-12 PCS 41 45 0.015
SF-12 MCS 57 58 0.795
Conclusions: In these patients, regaining function was the most im-
portant expectation for injection treatment. Improving ability to walk and
returning to recreational activity showed to be more important to patients
than reducing symptoms. Although patients had higher expectations for
improvement in knee function, Hylan G-F 20 with corticosteroid, showed
to signiﬁcantly improve function, and signiﬁcantly decrease pain. Hylan
G-F 20 and corticosteroid may be a good treatment option for older
patients suffering from osteoarthritis, who desire to return to an active
lifestyle.
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Purpose: The potential for intra-articular treatments to improve the med-
ical management of osteoarthritis (OA) continues to receive increasing
attention, particularly for patients in whom one or two problem joints drive
their disability. To improve the procedure for administering intra-articular
therapies, a new syringe-like device was speciﬁcally designed for mus-
culoskeletal aspiration/injection procedures. Termed the Reciprocating
Procedure Device (RPD), this device enables signiﬁcantly more precise
control of needle position, reduces procedure pain and trauma, increases
the volume of synovial ﬂuid that can be collected, and decreases the
time for performing intra-articular procedures (Arthritis & Rheumatism, in
press). These attributes are important for both therapy and biomarker
analysis. Corticosteroid and hyaluronan are the agents most commonly
administered by intra-articular injection, both of which require precise
delivery of the agent to the anatomical intra-articular space. In this trial
we hypothesized that the outcome of local therapy for OA was dependent
on the needle placement and needle control characteristics of the device
used for arthrocentesis and injection.
Methods: One hundred patients with symptomatic OA in a single large
joint were enrolled in an IRB-approved protocol, registered at clinical-
trials.gov. Patients were randomized to have arthrocentesis and intra-
articular corticosteroid injection performed using either the RPD or a
conventional syringe. The primary outcome measure was pain in the
affected joint, measured (1) at baseline (prior to the procedure), (2) during
local anesthesia, (3) during the arthrocentesis/injection procedure itself,
(4) at 2 weeks post-procedure, and (5) at 6 months post-procedure. Pain
was measured using a Visual Analogue Pain Scale (VAPS) (0 = no pain,
10 =most severe pain) with signiﬁcant pain being deﬁned as a VAPS
score >5.
Results: The group randomized to the RPD experienced signiﬁcantly
reduced pain scores during both local anesthesia administration (Syringe:
6.75±2.51; RPD: 3.63±1.98, p< 0.001), and during the arthrocente-
sis/injection procedure (Syringe: 4.25±2.51; RPD 2.54±1.98, p< 0.001).
With respect to longer term treatment outcomes, the RPD was signif-
icantly more effective than the conventional syringe in reducing pain
scores at 2 weeks (Syringe: 3.27±3.41; RPD: 1.89±0.98, p< 0.001),
the time point at which corticosteroid injections are expected to exhibit
their greatest efﬁcacy. Pain scores at 6 months trended toward improved
effectiveness for the RPD group (Syringe: 6.67±2.41; RPD: 4.89±2.98,
p = 0.06).
Conclusions: Though both groups experience the therapeutic beneﬁt
expected from intra-articular corticosteroid injection, this study demon-
strates that the device used to administer intra-articular therapy can inﬂu-
ence the safety and effectiveness of the procedure itself. Moreover, the
data demonstrate that the RPD signiﬁcantly improves patient outcomes
at two weeks post-injection, and suggests the potential for improved
therapeutic outcomes at six months. Considering the growing importance
of ofﬁce-based intra-articular procedures to OA treatment, the utility of the
RPD to substantially improve patient safety, comfort and outcomes should
be conﬁrmed in additional studies.
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Purpose: In comparison with WOMAC, the novel self-reported quanti-
tative index Knee Injury and Osteoarthritis Outcome Score (KOOS) has
two new subscales Sport/Recreation (SP/Rec) and Quality of Life (QL).
Recently the short form KOOS-PS was published (Perruccio et al 2008)
which focuses on some components of SP/Rec. There is evidence that
intensive turnover of collage type II takes place in early OA.
Aim: To investigate the associations of the functional limitations ex-
pressed by KOOS with emphasis on the Sp/Rec subscale with (i) ra-
diographic features of early KOA, (ii) degradation of type II collagen
and (iii) low-level inﬂammation in middle-aged women at baseline and
at 3 years.
Methods: A subset of women, including 100 subjects aged 34−54 years
(mean 45) at baseline, from a representative symptomatic cohort of Elva,
South-Estonia, was followed up. BMI> 26 was observed in 66% of the
women.
KOOS: The KOOS questionnaire includes the following subscales: Symp-
toms (S), Pain (P), Activities of daily life (ADL), Sport/recreation (SP/Rec)
and Quality of life (QL). An index value was calculated for every subscale
(0–100; better functional status is expressed by higher index value).
Radiographs: Antero-posterior weight-bearing radiographs of the tibio-
femoral compartment (TF) and axial radiographs of the patello-femoral
(PF) compartment of the knee joint were assessed.
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Degradation of the cartilage (type II collagen) was assessed by urinary
excretion of telopeptides, U-CTx-II (Nordic Bioscience).
Serum high-sensitive C-reactive protein (S-hs-CRP) was measured
by a particle-enchanced immunoturbidimetric assay.
Statistics: Spearman’s correlations and regression analysis were used.
Results: At baseline, only ADL (p = 0.02 and SP/Rec (p = 0.01) values
were signiﬁcantly lower in women with grade 1 TF OA in comparison with
those without OA. Three years later the KOOS values had deteriorated
and the associations were more pronounced. Now, all subscales of KOOS
demonstrated some correlation with TF osteophytosis and joint space
narrowing (JSN). Also correlations had appeared between PF JSN, and
P (p = 0.003), ADL (p = 0.01) and SP/Rec (p = 0.04).
At follow-up, U-CTx-II excretion correlated with SP/Rec (rho=-0.274,
p = 0.007) as well as with QL (rho=-0.213; p = 0.037). The association
between U-CTx-II and P was borderline (p = 0.055). A more detailed
study of the components of the SP/Rec subscale showed that four of
5 different demanding activities (squatting, running, jumpimg and kneel-
ing) correlated signiﬁcantly with U-CTx-II. (p = 0.003−0.008). S-hs-CRP
was associated with SP/Rec (rho =−0.61, p = 0.01) and ADL (p=-0.226,
p = 0.027) as well as with U-CTx-II (rho=0.318, p = 0.002), osteophytosis
and BMI.
Conclusions:
1. In middle-aged women slight decline in KOOS values might be asso-
ciated with stage I TF radiographic knee OA, which in most cases is
expressed by osteophytosis.
2. Functional limitations expressed by the subscales ADL and SP/Rec
are associated with low grade systemic inﬂammation.
3. Some decrease of KOOS SP/Rec values seems to be an early signs
of knee OA.
4. Squatting, running, jumping and kneeling were signiﬁcantly associated
with an increase in U-CTx-II and S-hs-CRP. Therefore one might as-
sume that in some subjects limitations by the KOOS SP/Rec subscale
are associated with intensiﬁed degradation of the joint cartilage.
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Purpose: Several options exist for arthroscopic treatment in the degen-
erative knee. With previous studies showing no improvement following
arthroscopy, it is crucial that a validated and east to use questionnaire is
applied to track the outcome of these procedures.
Methods: Test-retest reliability, content validity, criterion validity, construct
validity, and responsiveness to change were determined for the Lysholm
score and the Tegner activity scale in a group of patients diagnosed
at arthroscopy with osteoarthritis of the knee. For test-retest (n = 61),
patients completed a follow-up form and then completed a retest within
four weeks of the primary questionnaire. The intraclass correlation coefﬁ-
cient was determined for the domains and overall Lysholm score and for
the Tegner activity scale. An intraclass correlation coefﬁcient >0.70 was
considered acceptable. The standard error of the measurement (SEM)
was calculated. The minimum detectable change (MDC) was calculated to
determine the lowest change that can be considered a difference, taking
into account measurement error and noise. For criterion validity (n = 158),
the Tegner and Lysholm were compared to the WOMAC and SF-12. Hy-
potheses were developed by consensus and tested for construct validity
(n = 882). Preoperative and minimum one year postoperative scores were
compared to determine responsiveness (n = 294).
Results: The Tegner scale and overall Lysholm score showed acceptable
test-retest (ICC=0.87 & 0.79 respectively) reliability, ﬂoor and ceiling
effects, criterion validity, construct validity, and responsiveness to change.
The standard error of the Lysholm was 6.7 and the Minimum detectable
change at 95% conﬁdence level (MDC95) was16. For the Tegner score,
the standard error was 0.60 and the MDC95 was 1.2. For Lysholm internal
consistency, Cronbach’s alpha was >0.70. For construct validity, Tegner
levels and Lysholm scores were lower in patients with more severe
osteoarthritis, and difﬁculties with activities of daily living, working and
sports. Patients with abnormal knee function had lower Tegner level
and Lysholm scores. For criterion validity, Lysholm (r = −0.588, p< 0.01)
and Tegner (rho =−0.316, p< 0.01) were signiﬁcantly associated with
the overall WOMAC score. Both scores correlated to WOMAC Pain
component (Lysholm r = −0.563, p = 0.001; Tegner rho =−0.292, p = 0.001)
and the WOMAC Function component ( (Lysholm r = −0.581, p = 0.001;
Tegner rho =−0.344, p = 0.001). Both scores were also correlated with
the physical component of the Sf-12 (Tegner: r = 0.46, Lysholm: r = 0.641;
p< 0.01), however the scores did not correlate with the mental component
of the score. The Lysholm had a large effect size (1.01) and standardized
response mean (0.92). The Tegner had moderate effect size (0.80) and
standardized response mean (0.71).
Conclusions: The Lysholm & Tegner have been validated in ligament,
chondral, and meniscus pathogies. Although these scores were initially
developed to measure outcomes in patients with knee ligament injuries,
they have proven to valid in other common arthroscopic procedures.
The Lysholm knee score and Tegner activity scale demonstrated overall
acceptable psychometric performance for outcome measures for os-
teoarthritis of the knee. These scores provide the ability to collect function
and activity data on a one page form for a variety of pathologies. They
are simple to score, and have acceptable psychometric properties, which
make them useful research tools.
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Purpose: Osteoarthritis commonly affects the older, active patient.
Malalignment of the knee may increase the severity of osteoarthritis.
Unloader braces are designed to decrease the load on the degenerative
compartment of the knee in order to improve function and decrease
symptoms related to malalignment and osteoarthritis. The purpose of this
study is to document outcomes following 6 months of use of an unloader
brace. Outcomes and response to brace will be measured by symptoms,
such as pain and stiffness; function, use of pain medication and quality
of life.
Methods: Patients were enrolled in an IRB approved prospective cohort
study. Patients were excluded if they had any arthroplasty in the knee,
or moderate to severe osteoarthritis in both lateral and medial knee
compartments. Inclusion criteria were diagnosis of osteoarthritis of the
knee with unicompartmental knee conditions that required load reduction
to affected compartment and a minimum of a 6 month prescription in
order to allow for sufﬁcient trial of the brace. Patients signed informed
consent and agreed to complete all mailed questionnaires. At enrollment,
3 weeks, 6 weeks and 6 months, patients completed a self-administered
questionnaire. This questionnaire included the SF-12; the WOMAC score;
and anti-inﬂammatory use, both prescription and non-prescription.
Results: Thirty-nine patients were enrolled in this study. The average
age was 60 years (range 44 to 87). Average BMI was 26 (range 20 to
37). There were 22 males and 17 females. Twenty-ﬁve patients were
prescribed a medial unloader brace, while 14 were prescribed a lateral
unloader brace. Seven patients (18%), 5 females and 2 males, discontin-
ued brace wear.











Pre-brace 6.8 3.0 19 28.3 38.6 58.5
3 weeks 3.0 1.4 7.4 10.4 NA NA
6 weeks 3.4 1.4 9.8 13.5 42.5 56.6
6 months 2.9 1.5 8.6 11.9 46.0 59.4
At 3 weeks, 24% patients reported a decrease in over-the-counter
anti-inﬂammatories, and 16% reported a decrease in prescription anti-
inﬂammatories. At 6 months, 23% reported a decrease in over-the-
counter anti-inﬂammatories and 16% reported a decrease in prescription
anti-inﬂammatories.
Conclusions: In this population, the unloader brace decreased patients’
symptoms and improved function. Patients reduced medications and had
improved physical health.
